Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02483663 · ClinicalTrials.gov registry record

Brain Regulation of Appetite in Twins

A clinical trial of Obesity and Appetite, sponsored by University of Washington.

Completed
Registry status
122
Enrollment target
1
Study location

NCT02483663: Completed study of Obesity and Appetite, sponsored by University of Washington.

NCT02483663 is a study of Obesity and Appetite that has completed, run by University of Washington. The registered enrollment target is 122 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02483663, a study of Obesity and Appetite, has completed, sponsored by University of Washington.

COMPLETED
Registry status
122 participants
Enrollment target
1
Study location

Study Summary

Scientists are examining the genetic and environmental influences on appetite and weight gain. The main purpose of this study is to look at how genetic and environmental factors may influence how the brain regulates appetite and food intake. Understanding how the brain regulates appetite and food intake may eventually lead to new ways to help people avoid obesity or lose weight.

Conditions Studied

Interventions

  • OTHER Questionnaires
  • DEVICE Functional Magnetic Resonance Imaging
  • RADIATION Dual Energy X-ray absorptiometry
  • OTHER Mood and Appetite Ratings
  • OTHER Test Meals

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2010-08
Est. Completion 2015-08
University of Washington

1,048 total trials

What the finished NCT02483663 record still lists

NCT02483663 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.

NCT02483663 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02483663 about?

NCT02483663 is a clinical study titled "Brain Regulation of Appetite in Twins". Scientists are examining the genetic and environmental influences on appetite and weight gain. The main purpose of this study is to look at how genetic and environmental factors may influence how the brain regulates appetite and food intake. Understanding how the brain regulates appetite and food in...

What is the current status of trial NCT02483663?

This trial is currently completed. The enrollment target is 122 participants. The study started on 2010-08. Estimated completion is 2015-08.

What conditions does trial NCT02483663 study?

This clinical trial studies the following conditions: Obesity, Appetite.

What interventions are being tested in trial NCT02483663?

The interventions under investigation include: Questionnaires (OTHER), Functional Magnetic Resonance Imaging (DEVICE), Dual Energy X-ray absorptiometry (RADIATION), Mood and Appetite Ratings (OTHER), Test Meals (OTHER).

Who is sponsoring clinical trial NCT02483663?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02483663 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02483663's enrollment target sits among peer trials

122 432nd of 1053 higher than 621 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02483663, the US trial registry maintained by the National Library of Medicine. NCT02483663 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.